Effects of eicosapentaenoic acid on biological activity and inflammatory factor expression of human gingival fibroblasts

doi:10.19439/j.sjos.2021.03.001

Abstract

Abstract: PURPOSE: To explore the effects of eicosapentaenoic acid (EPA) on biological activity and inflammatory factor expression of human gingival fibroblasts (HGFs). METHODS: The effects of EPA on the activity, morphology and cell cycle of HGFs were observed by living and dead cell staining, immunofluorescence staining and flow cytometry, respectively. HGFs were stimulated by lipopolysaccharides (LPS) of Porphyromonas gingivalis (P. gingivalis) or heat inactivated P. gingivalis, after which the effects of EPA on mRNA and protein expression of IL-6, IL-8 and IL-1β were observed by real-time PCR and ELISA, respectively. The gene and protein expression of heme oxygenase-1(HO-1) was also detected by real-time PCR and Western blotting, respectively. The data were analyzed with SPSS 22.0 software package. RESULTS: 200 μmol/L EPA inhibited cell activity of HGFs; 100 μmol/L EPA did not affect cell activity and morphology of HGFs, and had no significant effect on cell cycle (P>0.05). EPA significantly downregulated gene expression of IL-6 and IL-1β, and protein expression of IL-6 stimulated by P. gingivalis LPS and heat-killed P.gingivalis(P<0.05), in a dose-dependent manner. EPA increased gene expression of HO-1 in a dose dependent manner(P<0.05), and upregulated HO-1 protein expression. CONCLUSIONS: EPA significantly inhibits the expression of inflammatory factors without affecting the biological activity of HGFs, which may be related to the induction of HO-1, suggesting the potential role of EPA in the prevention and treatment of periodontitis.

Key words: Eicosapentaenoic acid, Human gingival fibroblasts, Biological activity, Inflammatory factor

CLC Number:

R781.4

ZHOU Ke-cong, SUN Meng-jun, XIA Yi-ru, XIE Yu-feng, SHU Rong. Effects of eicosapentaenoic acid on biological activity and inflammatory factor expression of human gingival fibroblasts[J]. Shanghai Journal of Stomatology, 2021, 30(3): 225-231.

References

[1] Hajishengallis G, Chavakis T, Lambris JD.Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy[J]. Periodontol 2000, 2020, 84(1): 14-34.
[2] Scannapieco FA, Gershovich E.The prevention of periodontal disease-an overview[J]. Periodontol 2000, 2020, 84(1): 9-13.
[3] Chopra A, Bhat SG, Sivaraman K.Porphyromonas gingivalis adopts intricate and unique molecular mechanisms to survive and persist within the host: a critical update[J]. J Oral Microbiol, 2020, 12(1): 1801090.
[4] Suzumura A, Terao R, Kaneko H.Protective effects and molecular signaling of n-3 fatty acids on oxidative stress and inflammation in retinal diseases[J]. Antioxidants (Basel), 2020, 9(10): 920-928.
[5] Oppedisano F, Macrì R, Gliozzi M, et al.The anti-inflammatory and antioxidant properties of n-3 PUFAs: their role in cardiovascular protection[J]. Biomedicines, 2020, 8(9): 306-325.
[6] Sun M, Zhou Z, Dong J, et al.Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria[J]. Microb Pathog, 2016, 99: 196-203.
[7] 周子超. DHA和EPA对P.gingivalis LPS诱导人牙周膜成纤维细胞炎症反应的影响 [D]. 上海: 上海交通大学, 2015.
[8] Sheng H, Li P, Chen X, et al.Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1[J]. Front Biosci (Landmark Ed), 2014, 19: 854-861.
[9] Eser PO, Vanden Heuvel JP, Araujo J, et al.Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation[J]. Mol Clin Oncol, 2013, 1(3): 444-452.
[10] Meng H, Shen Y, Shen J, et al.Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer(PC-3) and prostate epithelial (RWPE-1) cells in vitro[J]. Lipids Health Dis, 2013, 12: 160-174.
[11] Xue M, Wang Q, Zhao J, et al.Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo [J]. J Nutr Biochem, 2014, 25(2): 104-110.
[12] Zajdel A, Wilczok A, Chodurek E, et al.Polyunsaturated fatty acids inhibit melanoma cell growth in vitro[J]. Acta Pol Pharm, 2013, 70(2): 365-369.
[13] Peng Y, Zheng Y, Zhang Y, et al.Different effects of omega-3 fatty acids on the cell cycle in C2C12 myoblast proliferation[J]. Mol Cell Biochem, 2012,367(1-2): 165-173.
[14] Barascu A, Besson P, Le Floch O, et al.CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells[J]. Int J Biochem Cell Biol, 2006, 38(2): 196-208.
[15] Li Q, Cui K, Wu M, et al.Polyunsaturated fatty acids influence LPS-induced inflammation of fish macrophages through differential modulation of pathogen recognition and p38 MAPK/NF-κB signaling[J]. Front Immunol, 2020, 11: 559332.
[16] Abekura Y, Ono I, Kawashima A, et al.Eicosapentaenoic acid prevents the progression of intracranial aneurysms in rats[J]. J Neuroinflammation, 2020, 17(1): 129-144.
[17] Oliver E, McGillicuddy FC, Harford KA, et al. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA[J]. J Nutr Biochem, 2012, 23(9): 1192-1200.
[18] Martinez-Micaelo N, González-Abuín N, Terra X, et al.Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation[J]. Biochem J, 2012, 441(2): 653-663.
[19] Wang Y, He J, Yang J.Eicosapentaenoic acid improves polycystic ovary syndrome in rats via sterol regulatory element-binding protein 1 (SREBP-1)/toll-like receptor 4 (TLR4) pathway[J]. Med Sci Monit, 2018, 24: 2091-2097.
[20] Solís-Martínez O, Plasa-Carvalho V, Phillips-Sixtos G, et al.Effect of eicosapentaenoic acid on body composition and inflammation markers in patients with head and neck squamous cell cancer from a public hospital in Mexico[J]. Nutr Cancer, 2018, 70(4): 663-670.
[21] Wang H, Khor TO, Saw CL, et al.Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid[J]. Mol Pharm, 2010, 7(6): 2185-2193.